These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9422584)

  • 21. Effect of education level on outcome of patients treated on Radiation Therapy Oncology Group Protocol 90-03.
    Konski A; Berkey BA; Kian Ang K; Fu KK
    Cancer; 2003 Oct; 98(7):1497-503. PubMed ID: 14508838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced head and neck carcinoma in women: treatment outcomes may not improve with accelerated hyperfractionated radiotherapy.
    Leborgne F; Leborgne JH; Fowler JF; Zubizarreta E; Mezzera J
    Cancer; 2001 Jun; 91(12):2353-60. PubMed ID: 11413525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma.
    Rosenthal DI; Ang KK
    Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New radiation therapy techniques for the treatment of head and neck cancer.
    Ding M; Newman F; Raben D
    Otolaryngol Clin North Am; 2005 Apr; 38(2):371-95, vii-viii. PubMed ID: 15823599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stochastic modelling of the role of cisplatin in altered fractionation schedules for head and neck cancer.
    Marcu L; Bezak E
    Phys Med; 2010 Oct; 26(4):177-83. PubMed ID: 20034829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of currently used radiobiological parameters with local control and acute and late mucosal toxicity in randomised studies of altered fractionation for locally advanced head and neck cancer.
    Hartley A; Sanghera P; Kazi W; Mehanna H; McConkey C; Glaholm J; Fowler J
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):29-33. PubMed ID: 20829006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant chemoradiotherapy versus altered fractionation radiotherapy in the radiotherapeutic management of locoregionally advanced head and neck squamous cell carcinoma: An adjusted indirect comparison meta-analysis.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    Head Neck; 2015 May; 37(5):670-6. PubMed ID: 24596112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Summary of major radiation fractionation and chemotherapy trials for organ preservation therapy in locally advanced head and neck squamous cell carcinoma.
    Parsons JT; Greene BD
    Pract Radiat Oncol; 2015; 5(5):343-349. PubMed ID: 25920699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New therapeutic strategy for head-and-neck neoplasms--Molecular target therapy].
    Fujii M
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Nov; 118(11):1369-74. PubMed ID: 26897759
    [No Abstract]   [Full Text] [Related]  

  • 30. [Individual patient data meta-analyses in head and neck carcinoma: what have we learnt?].
    Pignon JP; Baujat B; Bourhis J
    Cancer Radiother; 2005 Feb; 9(1):31-6. PubMed ID: 15804617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemoradiotherapy. Therapeutic indications: the doctor's point of view].
    Natale D; Orlando D
    Suppl Tumori; 2004; 3(4):S123-4. PubMed ID: 15206236
    [No Abstract]   [Full Text] [Related]  

  • 32. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
    Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C
    J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
    Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
    Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.
    Pignon JP; le Maître A; Bourhis J;
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S112-4. PubMed ID: 17848275
    [No Abstract]   [Full Text] [Related]  

  • 35. RTOG 9003: the untold story.
    Feigenberg S; Patel K; Amdur RJ; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):251-2. PubMed ID: 25304785
    [No Abstract]   [Full Text] [Related]  

  • 36. Predicting the future from trials of the past: epidermal growth factor receptor expression and outcome of fractionated radiation therapy trials.
    Dicker AP; Rodeck U
    J Clin Oncol; 2005 Aug; 23(24):5437-9. PubMed ID: 16110005
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.
    Brizel DM; Albers ME; Fisher SR; Scher RL; Richtsmeier WJ; Hars V; George SL; Huang AT; Prosnitz LR
    N Engl J Med; 1998 Jun; 338(25):1798-804. PubMed ID: 9632446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck.
    Khafif A; Canfield VA; Syzek EJ; Medina JE
    Am J Otolaryngol; 2003; 24(1):1-5. PubMed ID: 12579475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RTOG 9003: legacies of a landmark trial.
    Trotti A; Machtay M
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):253-4. PubMed ID: 25304786
    [No Abstract]   [Full Text] [Related]  

  • 40. [More frequent radiation therapy in the treatment of head and neck tumors].
    Holsti LR; Kajanti M
    Duodecim; 2005; 121(10):1025-6. PubMed ID: 15999504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.